HAI2024 Book - Flipbook - Page 13
performance equivalent or superior
to clinically used cerebrospinal fluid
tests ............................................. 570
Cogswell, Petrice ....................................... 574
Associations of C2N plasma
Aβ42/40 and p-tau217 and
subsequent amyloid PET change .574
Kac, Przemyslaw ....................................... 577
Plasma p-tau212 is increased in CSF
amyloid positive and
[18F]flutemetamol PET negative
cognitively impaired individuals .. 577
Attems, Johannes ..................................... 580
KEYNOTE: The multiple
neurodegenerative pathologies of
the ageing brain .......................... 580
Friday, January 19, 2024 - 11:50 am 02:30 pm ...................................... 581
Podium Session............................ 581
SESSION X: Plasma Applications ................. 581
Boerwinkle, Anna ....................................... 583
Plasma GFAP mediates the
relationship between amyloid and
tau PET in individuals with Down
Syndrome .....................................583
Dicks, Ellen ................................................ 586
Association of plasma GFAP with
FDG, PiB and tau PET across aging
HAI2024 - 13
and the Alzheimer’s disease
continuum ....................................586
Singh, Neha Atulkumar .............................. 589
Relationships between PET and
blood plasma biomarkers in
corticobasal syndrome ................589
Gogola, Alexandra...................................... 591
Evaluating the impact of
racialization on imaging and plasma
biomarkers ................................... 591
Rudolph, Marc............................................ 594
Plasma, MRI, and PET biomarkerbased risk prediction of dementia in
the context of health-related
comorbidities and demographic
factors: a preliminary exploration
..................................................... 594
Fajardo-Valdez, Alfonso ............................ 598
Longitudinal change of cerebral
amyloid and tau and its association
with plasma biomarkers in
preclinical Alzheimer's disease ...598
Duggan, Michael R. ....................................602
Proteome-wide analyses identifies
plasma immune regulators of
amyloid-beta progression .......... 602